Alimentiv
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Alimentiv sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Alimentiv: 7 sponsored US clinical trials, 4 recruiting.
Alimentiv sponsors 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 1 completed. 4 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Crohn's Disease, with 2 trials.
Upper-quartile sponsor footprint
Alimentiv sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
NCT06997965
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
NCT06670638
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
NCT06249555
Determination of the Optimal Treatment Target in Ulcerative Colitis
NCT04259138
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
NCT03765450
Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy
NCT01698307
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 4 |
Therapeutic Areas
Where Alimentiv enrollment is open (later-stage tilt)
4 recruiting of 7 indexed (57% open); 1 completed (14%).
Phase mix: 4 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Crohn's Disease (2 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Alimentiv: open-pipeline peers nationwide
Peers matched on 7 registered trials and 57% open enrollment, not the therapeutic-area sidebar.
Alimentiv sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 57% open enrollment (± trial volume)
- Aura Biosciences · 57% recruiting · 7 trials
- BicycleTx Limited · 57% recruiting · 7 trials
- Binghamton University · 57% recruiting · 7 trials
- Colorado Prevention Center · 57% recruiting · 7 trials
Related
What to do with this Alimentiv page
7 registered trials is a research-attention snapshot, not an endorsement of Alimentiv or any single study.
- 4 of Alimentiv's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Crohn's Disease is the condition Alimentiv studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Crohn's Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Alimentiv pipeline card: 7 registered trials from official public datasets.Report a data error.